Agenus/LinkedIn
Dec 21, 2024, 10:35
30 Years of Leadership in Immuno-Oncology – Agenus
Agenus shared on LinkedIn:
“For 30 years, we have been at the forefront of immuno-oncology. We’re proud of our cutting-edge manufacturing facilities, including our newest facility in California, designed to accelerate the commercialization of innovative therapies.
Equipped with cutting-edge technology and a fully integrated CGMP unit for biologics development and manufacturing, this state-of-the-art space enhances our ability to produce therapies more efficiently and at greater scale—ensuring faster access for patients in need.
Read more about our commitment to innovation and research.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 26, 2024, 09:17
Dec 26, 2024, 09:11
Dec 26, 2024, 06:29
Dec 26, 2024, 05:37
Dec 26, 2024, 05:33
Dec 26, 2024, 05:30
Dec 25, 2024, 22:43